Delivery Order SPE2DB20D9135-SPE2DB25FZV84

Award Date 11/15/24
Potential Completion Date 12/9/24
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide the KYLEENA 19.5 MG SYSTEMS pharmaceutical product. The $6,621.12 delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to supply various pharmaceutical and medical supplies to military treatment facilities worldwide. This delivery order has a completion date of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,814.82, is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which runs through December 31, 2025. The IDC allows...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of KYLEENA 19.5 MG SYSTEMS. The $3,098.45 contract has a completion date of July 3, 2025. DMS Pharmaceutical Group is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a comprehensive range of pharmaceutical products to federal agencies, particularly the military healthcare system. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,838.70 firm fixed-price contract is to provide the DLA with 4564738490 KYLEENA 19.5 MG SYSTEMS, a medical product. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,751.61 contract provides the DLA with the KYLEENA 19.5 MG SYSTEMS pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the agency to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,419.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4565423461 KYLEENA 19.5 MG SYSTEMS and does not have a set-aside designation. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, which provides a wide...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product KYLEENA 19.5 MG SYSTEMS. The contract has a completion date of February 7, 2024 and a potential value of $1,203.84. This delivery order is part of a larger indefinite delivery contract that DMS Pharmaceutical Group Inc. holds with the Defense Logistics Agency to provide various pharmaceutical and medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $6,196.90 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a medical product. The award is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,203.86 contract is for the delivery of 4566759551 - KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product, with a completion date of January 2, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $6,196.90 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB25FZV84
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,896.40 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the medical product "KYLEENA 19.5 MG SYSTEMS." This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The current delivery order has an ultimate completion date of December 9, 2024. This contract award is not associated with any set-aside designation.

Generated 2/14/25, 9:26 AM